[{"address1": "360 Massachusetts Avenue", "address2": "Suite 203", "city": "Acton", "state": "MA", "zip": "01720", "country": "United States", "phone": "844 327 7078", "website": "https://bluejaydx.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers Symphony platform, a technology platform comprising Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. It also provides ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 test for the monitoring of disease progression in critical care settings. Further, it develops cardiac biomarkers, such as hsTNT and NT pro-BNP, as well as other tests using the Symphony platform. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.", "fullTimeEmployees": 10, "companyOfficers": [{"maxAge": 1, "name": "Mr. Indranil  Dey", "age": 59, "title": "Principal Financial, Accounting & Executive Officer, President, CEO and Director", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 292154, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jason  Cook", "age": 41, "title": "Chief Technology Officer", "yearBorn": 1982, "fiscalYear": 2023, "totalPay": 240294, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Les  DeLuca", "title": "Vice President of Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Eryn  Graham", "title": "Marketing Manager", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kevin  Vance", "age": 65, "title": "Chief Commercial Officer", "yearBorn": 1958, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mark W. Feinberg", "title": "Chief Medical Advisor", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mark W. Feinberg M.D.", "title": "Chief Medical Advisor", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ryan  McSeveney", "title": "Corporate Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.359, "open": 0.34, "dayLow": 0.335, "dayHigh": 0.359, "regularMarketPreviousClose": 0.359, "regularMarketOpen": 0.34, "regularMarketDayLow": 0.335, "regularMarketDayHigh": 0.359, "beta": 0.808, "forwardPE": -1.04875, "volume": 249156, "regularMarketVolume": 249156, "averageVolume": 1321971, "averageVolume10days": 5766490, "averageDailyVolume10Day": 5766490, "marketCap": 1990799, "fiftyTwoWeekLow": 0.304, "fiftyTwoWeekHigh": 69.52, "fiftyDayAverage": 1.74296, "twoHundredDayAverage": 9.47554, "currency": "USD", "enterpriseValue": -2198104, "floatShares": 357338, "sharesOutstanding": 5932060, "sharesShort": 37743, "sharesShortPriorMonth": 15005, "sharesShortPreviousMonthDate": 1718323200, "dateShortInterest": 1721001600, "sharesPercentSharesOut": 0.0064, "heldPercentInsiders": 0.16618, "heldPercentInstitutions": 0.06981, "shortRatio": 0.04, "shortPercentOfFloat": 0.0064, "impliedSharesOutstanding": 5932060, "bookValue": 10.02, "priceToBook": 0.033493012, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -9742510, "trailingEps": -60.64, "forwardEps": -0.32, "lastSplitFactor": "1:8", "lastSplitDate": 1718841600, "enterpriseToEbitda": 0.231, "52WeekChange": -0.9941947, "SandP52WeekChange": 0.19031036, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "BJDX", "underlyingSymbol": "BJDX", "shortName": "Bluejay Diagnostics, Inc.", "longName": "Bluejay Diagnostics, Inc.", "firstTradeDateEpochUtc": 1636554600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "74bd969a-9ba0-37a6-9244-8da1cdf9cf23", "messageBoardId": "finmb_384143134", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.3356, "targetHighPrice": 256.0, "targetLowPrice": 256.0, "targetMeanPrice": 256.0, "targetMedianPrice": 256.0, "recommendationMean": 3.0, "recommendationKey": "hold", "numberOfAnalystOpinions": 1, "totalCash": 2661169, "totalCashPerShare": 7.33, "ebitda": -9511345, "totalDebt": 332728, "quickRatio": 1.744, "currentRatio": 2.261, "debtToEquity": 9.881, "returnOnAssets": -0.78771, "returnOnEquity": -1.5549899, "freeCashflow": -4569886, "operatingCashflow": -7676339, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-08-12"}]